Does MEROPENEM Cause Hypertransaminasaemia? 45 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 45 reports of Hypertransaminasaemia have been filed in association with MEROPENEM (Meropenem). This represents 0.3% of all adverse event reports for MEROPENEM.
45
Reports of Hypertransaminasaemia with MEROPENEM
0.3%
of all MEROPENEM reports
1
Deaths
33
Hospitalizations
How Dangerous Is Hypertransaminasaemia From MEROPENEM?
Of the 45 reports, 1 (2.2%) resulted in death, 33 (73.3%) required hospitalization.
Is Hypertransaminasaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MEROPENEM. However, 45 reports have been filed with the FAERS database.
What Other Side Effects Does MEROPENEM Cause?
Drug ineffective (2,802)
Off label use (1,572)
Condition aggravated (706)
Pyrexia (669)
Multiple organ dysfunction syndrome (655)
Drug reaction with eosinophilia and systemic symptoms (626)
Septic shock (613)
Drug resistance (539)
Acute kidney injury (522)
Rash (437)
What Other Drugs Cause Hypertransaminasaemia?
METHOTREXATE (436)
ACETAMINOPHEN (326)
PACLITAXEL (318)
CARBOPLATIN (304)
PEMBROLIZUMAB (231)
ATORVASTATIN (207)
CYCLOPHOSPHAMIDE (202)
PREDNISONE (198)
GEMCITABINE (196)
DEXAMETHASONE (169)
Which MEROPENEM Alternatives Have Lower Hypertransaminasaemia Risk?
MEROPENEM vs MEROPENEM ANHYDROUS
MEROPENEM vs MESALAMINE
MEROPENEM vs MESNA
MEROPENEM vs METAMIZOLE
MEROPENEM vs METARAMINOL